Expert Opinions and Guidelines Endocrinologists and obesity experts emphasize that GLP-1 therapies are effective but require ongoing monitoring, tailored dosing, and lifestyle support
The first GLP-1 medication received approval from the United States Food and Drug Administration in 2005
Key takeaways: Hashimotos and hypothyroidism do not automatically disqualify you Only medullary thyroid cancer and MEN-2 are true contraindications Weight loss may require thyroid medication adjustment Personalized endocrine care makes all the difference Whether youre located in Lafayette, San Francisco, the Bay Area, or anywhere in California via telemedicine , these decisions for my patients are always made through thoughtful, one-on-one discussions
"And that's why we see a lot of the effects that we see." Even patients who haven't had significant weight loss are "feeling so much better," Decotiis reported
GLP-1 medications like Ozempic (semaglutide) and Mounjaro (tirzepatide) have recently been gaining popularity and media attention for their beneficial effects in treating diabetes and promoting weight loss
Chances are, those people also made changes to their diet and activity patterns (and one of the groups was even counselled to do that) which could skew the results